Photo-catalytic and biomedical applications of one-step, plant extract-mediated green-synthesized cobalt oxide nanoparticles.

In the present work, for the first time, green chemically synthesized and stabilized Co3O4 nanoparticles were employed for catalytic conversion of isopropyl alcohol to acetone by dehydrogenation of IPA. Plant extract of Rosmarinus officinalis was used as a reducing and stabilizing agent for this synthesis. The biosynthesized Co3O4 nanoparticles were annealed at 450℃ followed by their physiochemical characterizations through XRD, SEM, AFM, and FTIR. Size distribution information collected through XRD and AFM back each other, and it was found to be 6.5 nm, having the highest number of nanoparticles in this size range. While SEM confirms the self-arranging property of synthesized nanoparticles due to their magnetic nature, furthermore, the biogenic Co3O4 nanoparticles were studied for their catalytic potential to convert isopropyl alcohol to acetone with the help of a UV-Visible spectrophotometer. The highest photocatalytic conversion of 99% was obtained in time period of 48 s. For the first time ever, nanoparticles were used for 5 cycles to evaluate their recyclable nature and conversion fell from 99 to 86% and the end of the 5th cycle. Later anti-bacterial activity against 3 Gram-positive and 3 Gram-negative strains gave the highest inhibition value of 99% against Streptococcus pneumoniae at 500 µg/mL. Finally, a cytotoxicity study on synthesized nanomaterials was carried out by exposing freshly drawn human macrophages to them. It was found that even at the highest concentration of 500 µg/mL, the nanoparticles showed only 28% lysis.

Floral extracts-mediated green synthesis of NiO nanoparticles and their diverse pharmacological evaluations.

Biosynthesis has emerged as an exciting interface for assembling multifunctional metal oxide nanoparticles for diverse medicinal applications. Herein, biogenic nickel oxide (NiO-NPs) is synthesized by using floral extracts of Callistemon viminalis (C. viminalis) as a low cost, ecofriendly reducing and stabilizing agent. NiO-NPs were annealed at 300 °C, 400 °C and 500 °C while their physiochemical properties were established by HR-SEM/TEM, UV, XRD, FTIR, EDS, SAED and SQUID techniques. Particle size of NiO-NPs decreased with increase in annealing temperatures. Magnetization curves indicated superparamagnetic behavior of the biogenic NiO-NPs at 300 K. Highly crystalline NiO-NPs obtained after annealing at 500 °C were used for biomedical applications. The anti-leishmanial activity on Leishmania tropica promastigotes (KMH-23) and anticancer activity on HepG2 (RCB1648) revealed excellent inhibition potential with IC50 of 37.21 µg/mL and 47 µg/mL, respectively. Significant antibacterial effect was observed against Klebsiella pneumonia and Proteus vulgaris with MIC's of 12.5 µg/mL each. Acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and α-glucosidase inhibitory potential were comparable with positive control drugs. Moderate antioxidant activities were observed. NiO-NPs were observed to be hemolytic (30%) at higher dose (1000 µg/mL). Overall, NiO-NPs revealed a multifunctional nature that can be explored for diverse biomedical applications.Communicated by Ramaswamy H. Sarma.